HomeFDMT • NASDAQ
4D Molecular Therapeutics Inc
add
$4.09
1.45%
After Hours:(0.00%)0.00
$4.09
Closed: Jun 18, 6:21:50 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 14.00K | -50.00% |
Operating expense | 12.94M | 25.67% |
Net income | -47.97M | -48.06% |
Net profit margin | -342.66K | -196.11% |
Earnings per share | -0.86 | -30.30% |
EBITDA | -52.57M | -42.22% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 321.44M | -38.88% |
Total assets | 515.73M | -18.12% |
Total liabilities | 46.01M | 56.89% |
Total equity | 469.72M | — |
Shares outstanding | 46.32M | — |
Price to book | 0.41 | — |
Return on assets | -24.91% | — |
Return on capital | -26.06% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -47.97M | -48.06% |
Cash from operations | -47.76M | -64.18% |
Cash from investing | 31.95M | 112.14% |
Cash from financing | — | — |
Net change in cash | -15.81M | -159.69% |
Free cash flow | -28.77M | -37.99% |
Previous close
$4.15
Day range
$4.05 - $4.26
Year range
$2.24 - $28.93
Market cap
189.47M USD
Avg Volume
470.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Headquarters
Website
Employees
227
